Related News
Doctors launch study on combination of TCM and western anti-viral therapy to improve hepatitis treatment
Online Edition
DOCTORS from Shuguang Traditional Chinese Medicine are cooperating with Ruijin Hospital to carry out a study on combination of TCM and western anti-viral therapy on patients with hepatitis.
The treatment targets the control of liver fibrosis to improve hepatitis treatment effects, experts told a medical forum yesterday.
“The study was part of the major scientific project in the nation. A total of 630 patients will participate the study and receive liver biopsy before and after the treatment,” said Hu Yiyang from Shuguang.
There are over 30 million people with hepatitis B in China and 40 percent of them can develop into liver cirrhosis through liver fibrosis.
Hu said TCM medicine involved in the study is a traditional herb combination called Fuzhenghuayu compound, which consists of six TCM medicines like Danshen, or the root of red-rooted salvia, Jiaogulan, or gynostemma pentaphyllum and cordyceps sinesis.
“We have fulfilled new drug study on the TCM and marketed it in 2002,” Hu said.
“Clinical trials home and abroad all confirmed its effects on hepatitis. This cooperation with Ruijin is to study how to further improve its effects on hepatitis patients. We expected the treatment effects can be improved by 15 percentage points with the combination of anti-viral therapy.”
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证：沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证：31120180004
- |
- 网络视听许可证：0909346
- |
- 广播电视节目制作许可证：沪字第354号
- |
- 增值电信业务经营许可证：沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
